低钠血症对胶质母细胞瘤患者生存期的预测潜力
本研究评估胶质母细胞瘤确诊时低钠血症是否与患者生存相关:在200例胶质母细胞瘤患者队列中,任何水平的血钠均与胶质母细胞瘤生存无显著相关,与其他多种癌症类型不同;在原位小鼠胶质母细胞瘤模型中诱导低钠血症对肿瘤进展和生存无影响。
要点
- 在200例胶质母细胞瘤患者队列中,任何水平的血钠均与胶质母细胞瘤生存无显著相关。
- 原位小鼠胶质母细胞瘤模型中诱导低钠血症对肿瘤进展和生存无影响。
- 血钠作为胶质母细胞瘤非侵入性预后标志物在本研究中未显示预测价值。
核心结论
- 在200例胶质母细胞瘤患者队列中,任何水平的血钠均与胶质母细胞瘤生存无显著相关。
- 在原位小鼠胶质母细胞瘤模型中诱导低钠血症对肿瘤进展和生存无影响。
研究设计与样本
- 研究评估胶质母细胞瘤确诊时低钠血症与患者生存的相关性,队列包含200例胶质母细胞瘤患者。
- 研究进一步在原位小鼠胶质母细胞瘤模型中诱导低钠血症,观察其对肿瘤进展和生存的影响。
主要发现
- 在200例胶质母细胞瘤患者队列中,任何水平的血钠均与胶质母细胞瘤生存无显著相关。
- 原位小鼠胶质母细胞瘤模型中诱导低钠血症对肿瘤进展和生存无影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioblastoma is a devastating malignancy with a dismal survival rate. Currently, there are limited prognostic markers of glioblastoma including IDH1, ATRX, MGMT, PTEN, EGFRvIII, and others. Although these biomarkers for tumor prognosis are available, a surgical biopsy must be performed for these analyses, which has morbidity involved. A non-invasive and readily available biomarker is sought after which provides clinicians prognostic information. Sodium is an electrolyte that is easily and quickly obtained through analysis of a patient's serum. Hyponatremia has been shown to have a predictive and negative prognostic indication in multiple cancer types, but the role of glioblastoma patients' serum sodium at the time of diagnosis in predicting glioblastoma patient survival has not been determined. We assessed whether hyponatremia at the time of glioblastoma diagnosis correlates to patient survival and show that in our cohort of 200 glioblastoma patients, sodium, at any level, did not significantly correlate to glioblastoma survival, unlike what is seen in multiple other cancer types. We further demonstrate that inducing hyponatremia in an orthotopic murine model of glioblastoma has no effects on tumor progression and survival.
引用
- Mrowczynski OD, Bourcier AJ, Liao J, et al. The predictive potential of hyponatremia for glioblastoma patient survival. J Neurooncol. 2018. PMID: 29372493. doi:10.1007/s11060-018-2774-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。